Dalbavancin Pharmacokinetics in an 18-Month-Old Child Undergoing Extracorporeal Membrane Oxygenation

Alessia Cafaro1, Giammarco Baiardi2,3, Alessio Mesini4

  • 1Biochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina, Gaslini, Genova, Italy.

PubMed

Insights

Extracorporeal membrane oxygenation (ECMO) significantly alters dalbavancin pharmacokinetics in children. ECMO increased drug clearance by over twofold, reducing its half-life and potentially impacting treatment efficacy.

Area of Science:

  • Pharmacology
  • Critical Care Medicine
  • Pediatrics

Background:

  • Extracorporeal membrane oxygenation (ECMO) provides life support for severe respiratory or cardiac failure.
  • Drug pharmacokinetics are frequently altered during ECMO, necessitating therapeutic drug monitoring.
  • Maintaining antimicrobial drug concentrations within the therapeutic range is crucial for patient outcomes.

Purpose of the Study:

  • To characterize the pharmacokinetic profile of dalbavancin in a pediatric patient undergoing ECMO.
  • To assess the impact of ECMO on dalbavancin clearance and half-life.

Main Methods:

  • A case presentation describing dalbavancin pharmacokinetics in an 18-month-old child.
  • Noncompartmental analysis was used to evaluate drug disposition during and after ECMO.

Main Results:

  • ECMO significantly increased dalbavancin clearance, estimated at 2.13 times higher compared to post-ECMO.
  • The terminal half-life of dalbavancin was reduced by 52.32% during ECMO (79.13 hours vs. 165.98 hours).

Conclusions:

  • ECMO profoundly alters dalbavancin pharmacokinetics, leading to increased clearance and reduced half-life.
  • These pharmacokinetic changes may result in suboptimal drug exposure, potentially compromising dalbavancin's efficacy during ECMO support.
Abstract

Related Concept Videos

Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
314
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
135
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.1K
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
151
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
124
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.0K